SG11202002968UA - Compound having erk kinase inhibitory activity and use thereof - Google Patents
Compound having erk kinase inhibitory activity and use thereofInfo
- Publication number
- SG11202002968UA SG11202002968UA SG11202002968UA SG11202002968UA SG11202002968UA SG 11202002968U A SG11202002968U A SG 11202002968UA SG 11202002968U A SG11202002968U A SG 11202002968UA SG 11202002968U A SG11202002968U A SG 11202002968UA SG 11202002968U A SG11202002968U A SG 11202002968UA
- Authority
- SG
- Singapore
- Prior art keywords
- compound
- inhibitory activity
- kinase inhibitory
- erk kinase
- erk
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710915493 | 2017-09-30 | ||
PCT/CN2018/108762 WO2019062949A1 (zh) | 2017-09-30 | 2018-09-29 | 具有erk激酶抑制活性的化合物及其用途 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202002968UA true SG11202002968UA (en) | 2020-04-29 |
Family
ID=65902341
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202002968UA SG11202002968UA (en) | 2017-09-30 | 2018-09-29 | Compound having erk kinase inhibitory activity and use thereof |
Country Status (15)
Country | Link |
---|---|
US (1) | US11465984B2 (ja) |
EP (1) | EP3702354A4 (ja) |
JP (1) | JP7216105B2 (ja) |
KR (1) | KR20200078510A (ja) |
CN (1) | CN109863147A (ja) |
AU (1) | AU2018339722B2 (ja) |
BR (1) | BR112020006294A2 (ja) |
CA (1) | CA3080623C (ja) |
EA (1) | EA202090888A1 (ja) |
IL (1) | IL273655B2 (ja) |
MX (1) | MX2020003240A (ja) |
NZ (1) | NZ763197A (ja) |
SG (1) | SG11202002968UA (ja) |
WO (1) | WO2019062949A1 (ja) |
ZA (1) | ZA202001823B (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023080193A1 (ja) * | 2021-11-04 | 2023-05-11 | 日産化学株式会社 | インドール化合物の製造方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106928216A (zh) | 2015-12-31 | 2017-07-07 | 中国科学院上海药物研究所 | 具有erk激酶抑制活性的化合物、其制备方法和用途 |
WO2017125534A1 (en) * | 2016-01-22 | 2017-07-27 | Janssen Pharmaceutica Nv | New 6-membered heteroaromatic substituted cyanoindoline derivatives as nik inhibitors |
US11180487B2 (en) * | 2016-01-22 | 2021-11-23 | Janssen Pharmaceutica Nv | Substituted cyanoindoline derivatives as NIK inhibitors |
-
2018
- 2018-09-29 IL IL273655A patent/IL273655B2/en unknown
- 2018-09-29 MX MX2020003240A patent/MX2020003240A/es unknown
- 2018-09-29 US US16/652,148 patent/US11465984B2/en active Active
- 2018-09-29 BR BR112020006294-4A patent/BR112020006294A2/pt unknown
- 2018-09-29 NZ NZ763197A patent/NZ763197A/en unknown
- 2018-09-29 JP JP2020539131A patent/JP7216105B2/ja active Active
- 2018-09-29 CA CA3080623A patent/CA3080623C/en active Active
- 2018-09-29 CN CN201880001907.6A patent/CN109863147A/zh active Pending
- 2018-09-29 KR KR1020207012147A patent/KR20200078510A/ko not_active Application Discontinuation
- 2018-09-29 SG SG11202002968UA patent/SG11202002968UA/en unknown
- 2018-09-29 EP EP18862819.2A patent/EP3702354A4/en active Pending
- 2018-09-29 AU AU2018339722A patent/AU2018339722B2/en active Active
- 2018-09-29 EA EA202090888A patent/EA202090888A1/ru unknown
- 2018-09-29 WO PCT/CN2018/108762 patent/WO2019062949A1/zh active Application Filing
-
2020
- 2020-03-23 ZA ZA2020/01823A patent/ZA202001823B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP3702354A4 (en) | 2021-02-24 |
CA3080623C (en) | 2023-10-10 |
IL273655B2 (en) | 2023-09-01 |
US11465984B2 (en) | 2022-10-11 |
AU2018339722A1 (en) | 2020-04-23 |
MX2020003240A (es) | 2020-11-24 |
EA202090888A1 (ru) | 2021-01-27 |
IL273655B1 (en) | 2023-05-01 |
BR112020006294A2 (pt) | 2020-10-06 |
JP2020536120A (ja) | 2020-12-10 |
KR20200078510A (ko) | 2020-07-01 |
EP3702354A1 (en) | 2020-09-02 |
NZ763197A (en) | 2024-03-22 |
CN109863147A (zh) | 2019-06-07 |
US20200247781A1 (en) | 2020-08-06 |
IL273655A (en) | 2020-05-31 |
JP7216105B2 (ja) | 2023-01-31 |
CA3080623A1 (en) | 2019-04-04 |
WO2019062949A1 (zh) | 2019-04-04 |
AU2018339722B2 (en) | 2022-06-30 |
ZA202001823B (en) | 2022-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA202001340B (en) | Heterocyclic compound and use thereof | |
EP3486244A4 (en) | NEW CONNECTION WITH FGF-INHIBITING EFFECT, PRODUCTION AND USE THEREOF | |
EP3620456A4 (en) | COMPOUND HAVING KINASE-INHIBITING ACTIVITY, PREPARATION METHOD AND USE THEREOF | |
EP3337375A4 (en) | BASKET AND DISHWASHER COMPRISING IT | |
SG10201913927VA (en) | Kinase inhibitors and uses thereof | |
PT3621694T (pt) | Inibidores de lrrc33 e sua utilização | |
EP3337376A4 (en) | BASKET AND DISHWASHER COMPRISING IT | |
EP3555051A4 (en) | HEPARANASE INHIBITORS AND USE THEREOF | |
IL280644A (en) | Magnesium serine compound and its use | |
KR102135648B9 (ko) | 항독성 또는 항병원성 활성을 갖는 레오이딘 화합물 및 이의 용도 | |
EP3564242A4 (en) | CONNECTION FOR THE SELECTIVE INHIBITION OF KINASE AND THEIR USE | |
SG11202012241RA (en) | Erk inhibitor and use thereof | |
EP3409668A4 (en) | NOVEL IMIDAZOLE DERIVATIVE HAVING JNK INHIBITORY ACTIVITY AND USE THEREOF | |
IL273655A (en) | A compound with erk kinase inhibitory activity and its use | |
EP3246312A4 (en) | Carbamate compound and use thereof | |
EP3246314A4 (en) | Carbamate compound and use thereof | |
EP3246319A4 (en) | Carbamate compound and use thereof | |
IL258370A (en) | Oxa-diazaspiro compounds with analgesic activity | |
IL283106A (en) | erk inhibitors and their uses | |
EP3246318A4 (en) | Carbamate compound and use thereof | |
EP3246316A4 (en) | Carbamate compound and use thereof | |
EP3607339A4 (en) | ACTIVE MRI | |
EP3555071A4 (en) | HEPARANASE INHIBITORS AND THEIR USE | |
EP3305895A4 (en) | Beta-galactosidase variant having high transglycosylation activity, and use thereof | |
IL284285A (en) | Domperidone combinations against neurodegeneration and use |